AGLE Annual ROE
-124.87%
-66.06%-112.33%
31 December 2022
Summary:
As of February 5, 2025, AGLE annual return on equity is -124.87%, with the most recent change of -66.06% (-112.33%) on December 31, 2022. During the last 3 years, it has fallen by -2.13% (-1.74%).AGLE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGLE Quarterly ROE
319.33%
+5134.86%+106.63%
30 September 2023
Summary:
As of February 5, 2025, AGLE quarterly return on equity is 319.33%, with the most recent change of +5134.86% (+106.63%) on September 30, 2023. Over the past year, it has increased by +426.29% (+398.55%).AGLE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGLE ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -112.3% | +398.6% |
| 3 y3 years | -1.7% | +477.7% |
| 5 y5 years | -159.7% | +610.0% |
AGLE ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +159.7% | at high |
Aeglea BioTherapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | 319.33%(-106.6%) |
| June 2023 | - | -4815.53%(+3580.8%) |
| Mar 2023 | - | -130.83%(+8.5%) |
| Dec 2022 | -124.87%(+112.3%) | -120.56%(+12.7%) |
| Sept 2022 | - | -106.96%(+10.2%) |
| June 2022 | - | -97.05%(+32.2%) |
| Mar 2022 | - | -73.42%(+26.9%) |
| Dec 2021 | -58.81%(-27.3%) | -57.86%(+5.6%) |
| Sept 2021 | - | -54.81%(+11.8%) |
| June 2021 | - | -49.02%(-27.4%) |
| Mar 2021 | - | -67.56%(-11.3%) |
| Dec 2020 | -80.93%(-34.1%) | -76.13%(-9.9%) |
| Sept 2020 | - | -84.54%(-11.7%) |
| June 2020 | - | -95.75%(-4.4%) |
| Mar 2020 | - | -100.12%(+8.3%) |
| Dec 2019 | -122.74% | -92.45%(+10.1%) |
| Sept 2019 | - | -83.95%(+13.9%) |
| June 2019 | - | -73.73%(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -73.19%(-1.4%) |
| Dec 2018 | -75.32%(+56.7%) | -74.21%(+18.5%) |
| Sept 2018 | - | -62.62%(+12.2%) |
| June 2018 | - | -55.79%(+3.3%) |
| Mar 2018 | - | -53.99%(+14.4%) |
| Dec 2017 | -48.08%(-54.8%) | -47.19%(+10.2%) |
| Sept 2017 | - | -42.81%(+13.1%) |
| June 2017 | - | -37.86%(-23.7%) |
| Mar 2017 | - | -49.64%(-28.5%) |
| Dec 2016 | -106.47%(+16.1%) | -69.42%(-48.7%) |
| Sept 2016 | - | -135.32%(+253.1%) |
| June 2016 | - | -38.32%(+7.7%) |
| Mar 2016 | - | -35.58%(+27.4%) |
| Dec 2015 | -91.71%(-83.4%) | -27.93%(-15.1%) |
| Sept 2015 | - | -32.89%(-6.7%) |
| June 2015 | - | -35.24%(-29.8%) |
| Mar 2015 | - | -50.21%(-90.9%) |
| Dec 2014 | -552.72% | -552.72% |
FAQ
- What is Aeglea BioTherapeutics annual return on equity?
- What is the all time high annual ROE for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics annual ROE year-on-year change?
- What is Aeglea BioTherapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics quarterly ROE year-on-year change?
What is Aeglea BioTherapeutics annual return on equity?
The current annual ROE of AGLE is -124.87%
What is the all time high annual ROE for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high annual return on equity is -48.08%
What is Aeglea BioTherapeutics annual ROE year-on-year change?
Over the past year, AGLE annual return on equity has changed by -66.06% (-112.33%)
What is Aeglea BioTherapeutics quarterly return on equity?
The current quarterly ROE of AGLE is 319.33%
What is the all time high quarterly ROE for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high quarterly return on equity is 319.33%
What is Aeglea BioTherapeutics quarterly ROE year-on-year change?
Over the past year, AGLE quarterly return on equity has changed by +426.29% (+398.55%)